Pulmonary surfactant ( PS ) compromises lipids and surfactant proteins (SP) and lines on the alveolar air-liquid interface. It can reduce surface tension, prevent alveoli from collapse and reduce alveoli edema by disaturated dipalmitoylphosphatidylcholine. It also modulates the pulmonary immunology by SP-A and SP-D. In this study,we established a rat model of immunocompromised host (ICH) with pulmonary infection of Pseudomonas aeruginosa (P. aeruginosa), then studied its pulmonary inflammatory reaction and analyzed the concentration of lipids and SP-A in bronchoalveolar lavage fluid (BALF) during infection.
Animals ; Bronchoalveolar Lavage Fluid ; chemistry ; microbiology ; Lipids ; analysis ; Lung ; microbiology ; Male ; Neutrophils ; physiology ; Pneumonia, Bacterial ; immunology ; metabolism ; Proteolipids ; analysis ; Pseudomonas Infections ; immunology ; metabolism ; Pulmonary Surfactant-Associated Protein A ; Pulmonary Surfactant-Associated Proteins ; Pulmonary Surfactants ; analysis ; Rats ; Rats, Sprague-Dawley